News

Published on 7 Nov 2024 on Zacks

Moderna Stock Rises on Q3 Earnings & Sales Beat, Reiterates View


Article preview image

Free Report) reported earnings of 3 cents per share in the third quarter of 2024. The Zacks...

NASDAQ.MRNA price evolution
NASDAQ.BIIB price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Moderna Stock Rises on Q3 Earnings & Sales Beat, Reiterates View

Free Report) reported earnings of 3 cents per share in the third quarter of 2024. The Zacks...

Zacks 7 Nov 2024

Biogen raises 2024 outlook on strong Alzheimer's drug sales - Boston Business...

Biogen Inc. is now projecting better full-year financial results that it was a few months ago as ...

The Business Journals 30 Oct 2024

Biogen Raises Forecast as Alzheimer’s Drug Leqembi Shows Signs of Growth

(Bloomberg) -- Biogen Inc. raised its annual earnings guidance after reporting better-than-expect...

Bloomberg · via Yahoo Finance 30 Oct 2024

Earnings call: Biogen reports progress and strategic pipeline expansion By...

Biogen Inc. (NASDAQ:BIIB), a leading biotechnology company, shared its third-quarter financial...

Investing.com 30 Oct 2024

Biogen appoints insider as CFO after Michael McDonnell to retire next year

, opens new tab said on Monday insider Robin Kramer will take over as the drugmaker's finance chi...

Reuters 28 Oct 2024

Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now

We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 20 Oct 2024

Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts?

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this artic...

Insider Monkey · via Yahoo Finance 20 Oct 2024

Biogen Inc. (BIIB): Worst Performing NASDAQ Stock in 2024

We recently compiled a list of the 10 Worst Performing NASDAQ Stocks in 2024. In this article, we...

Insider Monkey · via Yahoo Finance 19 Oct 2024

Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody

Biogen BIIB announced that the European Commission (EC) has granted marketing approval to Qalsody...

Zacks via Yahoo Finance 31 May 2024

Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder

Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder...

Benzinga via Yahoo Finance 31 May 2024